Annual SG&A
$80.31 M
+$11.07 M+15.98%
31 December 2023
Summary:
BioLife Solutions annual selling, general & administrative expenses is currently $80.31 million, with the most recent change of +$11.07 million (+15.98%) on 31 December 2023. During the last 3 years, it has risen by +$58.62 million (+270.32%). BLFS annual SG&A is now at all-time high.BLFS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$14.89 M
+$498.00 K+3.46%
30 September 2024
Summary:
BioLife Solutions quarterly selling, general & administrative expenses is currently $14.89 million, with the most recent change of +$498.00 thousand (+3.46%) on 30 September 2024. Over the past year, it has dropped by -$795.00 thousand (-5.07%). BLFS quarterly SG&A is now -50.37% below its all-time high of $30.01 million, reached on 31 December 2023.BLFS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.33 B
-$47.60 M-3.71%
30 September 2024
Summary:
BioLife Solutions TTM selling, general & administrative expenses is currently -$1.33 billion, with the most recent change of -$47.60 million (-3.71%) on 30 September 2024. Over the past year, it has dropped by -$1.40 billion (-1926.67%). BLFS TTM SG&A is now -266279.40% below its all-time high of $84.38 million, reached on 31 December 2023.BLFS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.0% | -5.1% | -1926.7% |
| 3 y3 years | +270.3% | +5.3% | -3557.2% |
| 5 y5 years | +837.6% | +313.9% | -10000.0% |
BLFS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +270.3% | -50.4% | +5.3% | -253.2% | at low |
| 5 y | 5 years | at high | +837.6% | -50.4% | +313.9% | -345.1% | at low |
| alltime | all time | at high | >+9999.0% | -50.4% | +2778.8% | <-9999.0% | at low |
BioLife Solutions Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $14.89 M(+3.5%) | $77.30 M(-1.0%) |
| June 2024 | - | $14.40 M(-20.0%) | $78.10 M(-3.7%) |
| Mar 2024 | - | $18.00 M(-40.0%) | $81.07 M(-3.9%) |
| Dec 2023 | $80.31 M(+16.0%) | $30.01 M(+91.3%) | $84.38 M(+15.7%) |
| Sept 2023 | - | $15.69 M(-9.7%) | $72.91 M(-2.0%) |
| June 2023 | - | $17.37 M(-18.5%) | $74.42 M(+0.4%) |
| Mar 2023 | - | $21.31 M(+15.0%) | $74.11 M(+7.1%) |
| Dec 2022 | $69.24 M(+45.2%) | $18.54 M(+7.8%) | $69.22 M(+3.2%) |
| Sept 2022 | - | $17.19 M(+0.7%) | $67.07 M(+4.8%) |
| June 2022 | - | $17.07 M(+3.9%) | $64.02 M(+11.8%) |
| Mar 2022 | - | $16.42 M(+0.2%) | $57.24 M(+20.1%) |
| Dec 2021 | $47.67 M(+119.8%) | $16.39 M(+15.8%) | $47.67 M(+23.7%) |
| Sept 2021 | - | $14.15 M(+37.5%) | $38.52 M(+30.7%) |
| June 2021 | - | $10.29 M(+50.2%) | $29.47 M(+23.7%) |
| Mar 2021 | - | $6.85 M(-5.4%) | $23.83 M(+9.9%) |
| Dec 2020 | $21.69 M(+59.5%) | $7.24 M(+42.2%) | $21.69 M(+18.5%) |
| Sept 2020 | - | $5.09 M(+9.6%) | $18.30 M(+8.9%) |
| June 2020 | - | $4.64 M(-1.4%) | $16.81 M(+9.7%) |
| Mar 2020 | - | $4.71 M(+22.2%) | $15.32 M(+12.7%) |
| Dec 2019 | $13.59 M(+58.7%) | $3.85 M(+7.1%) | $13.60 M(+12.1%) |
| Sept 2019 | - | $3.60 M(+14.1%) | $12.13 M(+13.2%) |
| June 2019 | - | $3.15 M(+5.4%) | $10.71 M(+11.7%) |
| Mar 2019 | - | $2.99 M(+25.2%) | $9.59 M(+12.0%) |
| Dec 2018 | $8.56 M(+29.6%) | $2.39 M(+9.5%) | $8.56 M(+7.9%) |
| Sept 2018 | - | $2.18 M(+7.3%) | $7.94 M(+7.8%) |
| June 2018 | - | $2.03 M(+3.4%) | $7.37 M(+5.9%) |
| Mar 2018 | - | $1.97 M(+11.4%) | $6.96 M(+5.3%) |
| Dec 2017 | $6.61 M(-13.1%) | $1.76 M(+9.7%) | $6.61 M(+3.1%) |
| Sept 2017 | - | $1.61 M(-1.0%) | $6.41 M(-3.7%) |
| June 2017 | - | $1.62 M(+0.5%) | $6.66 M(-6.8%) |
| Mar 2017 | - | $1.62 M(+3.2%) | $7.15 M(-6.0%) |
| Dec 2016 | $7.60 M(+2.0%) | $1.57 M(-15.6%) | $7.60 M(-6.8%) |
| Sept 2016 | - | $1.86 M(-12.2%) | $8.15 M(-1.0%) |
| June 2016 | - | $2.11 M(+2.1%) | $8.24 M(+5.6%) |
| Mar 2016 | - | $2.07 M(-2.3%) | $7.80 M(+4.7%) |
| Dec 2015 | $7.45 M(+40.6%) | $2.12 M(+9.2%) | $7.45 M(+6.8%) |
| Sept 2015 | - | $1.94 M(+16.0%) | $6.98 M(+9.9%) |
| June 2015 | - | $1.67 M(-2.8%) | $6.35 M(+7.3%) |
| Mar 2015 | - | $1.72 M(+4.6%) | $5.92 M(+11.6%) |
| Dec 2014 | $5.30 M(+48.9%) | $1.64 M(+25.6%) | $5.30 M(+12.0%) |
| Sept 2014 | - | $1.31 M(+5.6%) | $4.73 M(+11.1%) |
| June 2014 | - | $1.24 M(+12.2%) | $4.26 M(+11.0%) |
| Mar 2014 | - | $1.11 M(+2.5%) | $3.84 M(+7.8%) |
| Dec 2013 | $3.56 M(+28.5%) | $1.08 M(+28.6%) | $3.56 M(+3.8%) |
| Sept 2013 | - | $838.40 K(+2.7%) | $3.43 M(+6.4%) |
| June 2013 | - | $816.40 K(-1.3%) | $3.23 M(+5.9%) |
| Mar 2013 | - | $827.20 K(-12.9%) | $3.05 M(+9.9%) |
| Dec 2012 | $2.77 M(+32.2%) | $949.40 K(+49.9%) | $2.77 M(+17.2%) |
| Sept 2012 | - | $633.50 K(-0.3%) | $2.36 M(+3.4%) |
| June 2012 | - | $635.70 K(+15.1%) | $2.29 M(+8.3%) |
| Mar 2012 | - | $552.50 K(+1.9%) | $2.11 M(+0.7%) |
| Dec 2011 | $2.10 M(+8.5%) | $542.30 K(-2.4%) | $2.10 M(+4.6%) |
| Sept 2011 | - | $555.90 K(+20.7%) | $2.00 M(+7.7%) |
| June 2011 | - | $460.60 K(-14.3%) | $1.86 M(-2.3%) |
| Mar 2011 | - | $537.70 K(+19.4%) | $1.90 M(-1.4%) |
| Dec 2010 | $1.93 M(-21.1%) | $450.50 K(+9.2%) | $1.93 M(+1.8%) |
| Sept 2010 | - | $412.70 K(-18.1%) | $1.90 M(-3.3%) |
| June 2010 | - | $503.60 K(-11.0%) | $1.96 M(-13.4%) |
| Mar 2010 | - | $565.60 K(+35.6%) | $2.27 M(-7.4%) |
| Dec 2009 | $2.45 M(-4.3%) | $417.00 K(-12.7%) | $2.45 M(-11.6%) |
| Sept 2009 | - | $477.40 K(-41.0%) | $2.77 M(-6.5%) |
| June 2009 | - | $808.50 K(+8.3%) | $2.96 M(+9.9%) |
| Mar 2009 | - | $746.60 K(+1.1%) | $2.70 M(+5.4%) |
| Dec 2008 | $2.56 M | $738.70 K(+10.5%) | $2.56 M(+13.5%) |
| Sept 2008 | - | $668.50 K(+23.4%) | $2.25 M(-6.1%) |
| June 2008 | - | $541.90 K(-10.9%) | $2.40 M(-6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $608.50 K(+40.3%) | $2.57 M(-1.7%) |
| Dec 2007 | $2.61 M(+49.9%) | $433.80 K(-46.8%) | $2.61 M(-3.7%) |
| Sept 2007 | - | $815.50 K(+15.2%) | $2.71 M(+15.9%) |
| June 2007 | - | $707.70 K(+8.2%) | $2.34 M(+10.0%) |
| Mar 2007 | - | $653.80 K(+22.6%) | $2.13 M(+22.0%) |
| Dec 2006 | $1.74 M(+80.7%) | $533.20 K(+20.4%) | $1.74 M(+19.4%) |
| Sept 2006 | - | $443.00 K(-10.6%) | $1.46 M(+14.2%) |
| June 2006 | - | $495.30 K(+83.0%) | $1.28 M(+26.6%) |
| Mar 2006 | - | $270.70 K(+8.4%) | $1.01 M(+4.7%) |
| Dec 2005 | $964.30 K(-11.7%) | $249.70 K(-4.5%) | $964.20 K(+6.8%) |
| Sept 2005 | - | $261.60 K(+15.2%) | $903.20 K(+3.5%) |
| June 2005 | - | $227.10 K(+0.6%) | $872.60 K(-6.6%) |
| Mar 2005 | - | $225.80 K(+19.7%) | $934.10 K(-14.5%) |
| Dec 2004 | $1.09 M(-11.1%) | $188.70 K(-18.3%) | $1.09 M(+31.0%) |
| Sept 2004 | - | $231.00 K(-20.0%) | $833.50 K(-22.9%) |
| June 2004 | - | $288.60 K(-24.8%) | $1.08 M(-11.1%) |
| Mar 2004 | - | $383.80 K(-649.1%) | $1.22 M(+0.1%) |
| Dec 2003 | $1.23 M(+49.0%) | -$69.90 K(-114.6%) | $1.21 M(-28.0%) |
| Sept 2003 | - | $478.50 K(+13.0%) | $1.69 M(+25.2%) |
| June 2003 | - | $423.60 K(+10.8%) | $1.35 M(+12.8%) |
| Mar 2003 | - | $382.40 K(-5.1%) | $1.19 M(+30.9%) |
| Dec 2002 | $824.10 K(+371.7%) | $402.90 K(+190.7%) | $912.20 K(+67.7%) |
| Sept 2002 | - | $138.60 K(-48.8%) | $543.90 K(+25.9%) |
| June 2002 | - | $270.60 K(+170.3%) | $431.90 K(+106.9%) |
| Mar 2002 | - | $100.10 K(+189.3%) | $208.70 K(-78.4%) |
| Dec 2001 | $174.70 K(-91.9%) | $34.60 K(+30.1%) | $967.40 K(-49.6%) |
| Sept 2001 | - | $26.60 K(-43.9%) | $1.92 M(-16.0%) |
| June 2001 | - | $47.40 K(-94.5%) | $2.28 M(-17.9%) |
| Mar 2001 | - | $858.80 K(-13.0%) | $2.78 M(+29.3%) |
| Dec 2000 | $2.15 M(+69.4%) | $987.30 K(+152.4%) | $2.15 M(+84.8%) |
| Sept 2000 | - | $391.20 K(-28.1%) | $1.16 M(+50.6%) |
| June 2000 | - | $544.30 K(+138.6%) | $772.40 K(+238.6%) |
| Mar 2000 | - | $228.10 K(-50.7%) | $228.10 K(-86.3%) |
| Dec 1999 | $1.27 M(-23.7%) | - | - |
| Dec 1998 | $1.66 M(-17.5%) | $463.00 K(+15.8%) | $1.66 M(-8.4%) |
| Sept 1998 | - | $400.00 K(0.0%) | $1.82 M(0.0%) |
| June 1998 | - | $400.00 K(0.0%) | $1.82 M(-9.9%) |
| Mar 1998 | - | $400.00 K(-35.1%) | $2.02 M(-4.7%) |
| Dec 1997 | $2.02 M(+31.4%) | $616.30 K(+54.1%) | $2.12 M(+41.1%) |
| Sept 1997 | - | $400.00 K(-33.3%) | $1.50 M(-21.1%) |
| June 1997 | - | $600.00 K(+20.0%) | $1.90 M(+5.0%) |
| Mar 1997 | - | $500.00 K(-37.5%) | $1.81 M(-58.0%) |
| Dec 1996 | $1.53 M(-69.4%) | - | - |
| Sept 1996 | - | $800.00 K(+56.8%) | $4.31 M(-14.0%) |
| June 1996 | - | $510.20 K(-63.6%) | $5.01 M(+27.0%) |
| June 1996 | $5.01 M(-25.7%) | - | - |
| Mar 1996 | - | $1.40 M(-12.5%) | $3.94 M(-21.8%) |
| Dec 1995 | - | $1.60 M(+6.7%) | $5.04 M(+46.5%) |
| Sept 1995 | - | $1.50 M(-369.8%) | $3.44 M(-16.9%) |
| June 1995 | $6.74 M(-25.1%) | -$556.00 K(-122.2%) | $4.14 M(-40.8%) |
| Mar 1995 | - | $2.50 M(+13.6%) | $7.00 M(-23.9%) |
| Sept 1994 | - | $2.20 M(-4.3%) | $9.20 M(+3.4%) |
| June 1994 | $9.00 M(+13.9%) | $2.30 M(-4.2%) | $8.90 M(-6.3%) |
| Mar 1994 | - | $2.40 M(+4.3%) | $9.50 M(+5.6%) |
| Dec 1993 | - | $2.30 M(+21.1%) | $9.00 M(+7.1%) |
| Sept 1993 | - | $1.90 M(-34.5%) | $8.40 M(+5.0%) |
| June 1993 | $7.90 M(+276.2%) | $2.90 M(+52.6%) | $8.00 M(+56.9%) |
| Mar 1993 | - | $1.90 M(+11.8%) | $5.10 M(+59.4%) |
| Dec 1992 | - | $1.70 M(+13.3%) | $3.20 M(+68.4%) |
| Sept 1992 | - | $1.50 M(+275.0%) | $1.90 M(+375.0%) |
| June 1992 | $2.10 M(+50.0%) | - | - |
| Dec 1991 | - | $400.00 K(0.0%) | $400.00 K(0.0%) |
| June 1991 | $1.40 M(+75.0%) | - | - |
| Sept 1990 | - | $400.00 K | $400.00 K |
| June 1990 | $800.00 K(+300.0%) | - | - |
| June 1989 | $200.00 K | - | - |
FAQ
- What is BioLife Solutions annual selling, general & administrative expenses?
- What is the all time high annual SG&A for BioLife Solutions?
- What is BioLife Solutions annual SG&A year-on-year change?
- What is BioLife Solutions quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for BioLife Solutions?
- What is BioLife Solutions quarterly SG&A year-on-year change?
- What is BioLife Solutions TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for BioLife Solutions?
- What is BioLife Solutions TTM SG&A year-on-year change?
What is BioLife Solutions annual selling, general & administrative expenses?
The current annual SG&A of BLFS is $80.31 M
What is the all time high annual SG&A for BioLife Solutions?
BioLife Solutions all-time high annual selling, general & administrative expenses is $80.31 M
What is BioLife Solutions annual SG&A year-on-year change?
Over the past year, BLFS annual selling, general & administrative expenses has changed by +$11.07 M (+15.98%)
What is BioLife Solutions quarterly selling, general & administrative expenses?
The current quarterly SG&A of BLFS is $14.89 M
What is the all time high quarterly SG&A for BioLife Solutions?
BioLife Solutions all-time high quarterly selling, general & administrative expenses is $30.01 M
What is BioLife Solutions quarterly SG&A year-on-year change?
Over the past year, BLFS quarterly selling, general & administrative expenses has changed by -$795.00 K (-5.07%)
What is BioLife Solutions TTM selling, general & administrative expenses?
The current TTM SG&A of BLFS is -$1.33 B
What is the all time high TTM SG&A for BioLife Solutions?
BioLife Solutions all-time high TTM selling, general & administrative expenses is $84.38 M
What is BioLife Solutions TTM SG&A year-on-year change?
Over the past year, BLFS TTM selling, general & administrative expenses has changed by -$1.40 B (-1926.67%)